James R. Montero

FDA investigator

Appears on 10 documents from 2014 to 2025, mostly at sites in Utah. Most often cites corrective and preventive action (21 CFR 820.100).

10
Documents on file
6.1
Observations per 483
2014
First seen
2025
Most recent

What they cite most

From 60 observations

Activity by year

2014: 1, 2015: 2, 2016: 2, 2019: 1, 2021: 1, 2024: 2, 2025: 1

Where

Utah 6 · California 2 · Germany 1 · Wyoming 1

Is James R. Montero coming to your site?

Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.

Ask about any investigator in Claude or ChatGPT with the AI connector.

Inspection history

10 documents, newest first
FirmOpen
483 ASEPTIKITS, LLCDec 3, 2025 · North Salt Lake, Utah
483 Dexcom, IncNov 7, 2024 · San Diego, California
483 Form 483 · FEI 3021769057Jul 31, 2024 · Cypress, California
483 International Medical Development, Inc. 560 Highway 39Feb 12, 2021 · Huntsville, Utah
483 BPI LabsJun 12, 2019 · Evanston, Wyoming
483 Novarad CorporationMar 30, 2016 · American Fork, Utah
483 Trokamed GmbHFeb 19, 2016 · Geisingen, Germany

About this profile

What does James R. Montero inspect?

James R. Montero appears on 10 documents on file covering 9 sites, mostly in Utah.

What do they cite most often?

21 CFR 820.100 (corrective and preventive action), followed by 21 CFR 820.30 and 21 CFR 820.198.

Can I read the observations?

Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.

How current is this profile?

The most recent document on file for James R. Montero is dated Dec 3, 2025.